Efficacy and safety of hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and tyrosine kinase inhibitors in advanced hepatocellular carcinoma: A systematic review and meta‑analysis

At present, hepatic arterial infusion chemotherapy (HAIC) for the treatment of hepatocellular carcinoma (HCC) is often applied to patients who are not suitable or are unwilling to undergo surgical treatment. However, to the best of our knowledge, the efficacy and safety of HAIC combined with immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zixiong, Xu, Yanping, Qu, Wenshu, Liu, Ping, Zhu, Yan, Li, Hui, Guo, Ying, Liu, Xiufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655037/
https://www.ncbi.nlm.nih.gov/pubmed/38020293
http://dx.doi.org/10.3892/ol.2023.14121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655037/
https://www.ncbi.nlm.nih.gov/pubmed/38020293
http://dx.doi.org/10.3892/ol.2023.14121

Ejemplares similares